Výsledky vyhledávání - "18 F-FET PET"

Radiotherapy target volume definition in newly diagnosed high grade glioma using 18F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG)

Autor: David Bourhis, Pierre-Yves Salaun, Dorothy M. Gujral, Ulrike Schick, Douraied Ben Salem, Olivier Pradier, Osman El Kabbaj, Romuald Seizeur, Solène Querellou, Brieg Dissaux, Gurvan Dissaux

Publikováno v: Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2020, 150, pp.164-171. ⟨10.1016/j.radonc.2020.06.025⟩
Radiotherapy & Oncology
Radiotherapy & Oncology, 2020, 150, pp.164-171. ⟨10.1016/j.radonc.2020.06.025⟩

International audience; Purpose: The aim of this study was to prospectively investigate tumor volume delineation by amino acid PET and multiparametric perfusion magnetic resonance imaging (MRI) in patients with newly diagnosed, untreated high grade g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1020f4d7b4c7b8cfe0abd39ca8697d62
https://hal.archives-ouvertes.fr/hal-03492289

Zobrazit plný text záznamu

PET Imaging in Glioblastoma: Use in Clinical Practice

Autor: Karl-Josef Langen, Antoine Verger

Publikováno v: Glioblastoma
Glioblastoma, Codon Publications, pp.155-174, 2017, ⟨10.15586/codon.glioblastoma.2017.ch9⟩
Glioblastoma ISBN: 9780994438126

Positron emission tomography (PET) is a nuclear medicine imaging method with increasing relevance for the diagnosis, prognostication, and monitoring of glioblastomas. PET provides additional insight beyond magnetic resonance imaging (MRI) into the bi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c472ab027775e72e6c760cc9cf4edf0
https://hal.univ-lorraine.fr/hal-03268418/document

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Initial Experience of ¹⁸ F-FET PET-MR Image Fusion for Evaluation of Recurrent Primary Brain Tumors.

Autor: Dadgar H; Cancer Research Center, RAZAVI Hospital, Imam Reza International University, Mashhad, Iran., Vafaee MS; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Translational Neuroscience, BRIDGE, University of Southern Denmark, Odense, Denmark.; Department of Psychiatry, Odense University Hospital, Odense, Denmark., Khorasanchi A; Cancer Research Center, RAZAVI Hospital, Imam Reza International University, Mashhad, Iran., Moghadam PK; Social Determinants of Health Research Center (Division of Cognitive Neuroscience), Lorestan University of Medical Sciences, Khorramabad, Iran., Nemati R; Department of Neurology, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran., Shooli H; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy (MIRT), Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran., Jafari E; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy (MIRT), Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran., Assadi M; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy (MIRT), Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.

Publikováno v: World journal of nuclear medicine [World J Nucl Med] 2023 Sep 06; Vol. 22 (3), pp. 183-190. Date of Electronic Publication: 2023 Sep 06 (Print Publication: 2023).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Radiotherapy target volume definition in newly diagnosed high grade glioma using ¹⁸ F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG).

Autor: Dissaux G; Radiation Oncology Department, University Hospital, Brest, France; Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM 1101, Brest, France. Electronic address: gurvan.dissaux@chu-brest.fr., Dissaux B; Radiology Department, University Hospital, Brest, France; EA 3878 GETBO IFR 148, Brest, France; Université de Bretagne Occidentale, Brest, France., Kabbaj OE; Radiation Oncology Department, University Hospital, Brest, France., Gujral DM; Clinical Oncology Department, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Hammersmith, London, United Kingdom; Department of Cancer and Surgery, Imperial College London, London, United Kingdom., Pradier O; Radiation Oncology Department, University Hospital, Brest, France; Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM 1101, Brest, France., Salaün PY; Nuclear Medicine Department, University Hospital, Brest, France; EA 3878 GETBO IFR 148, Brest, France; Université de Bretagne Occidentale, Brest, France., Seizeur R; Neurosurgery Department, University Hospital, Brest, France; Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM 1101, Brest, France., Bourhis D; Nuclear Medicine Department, University Hospital, Brest, France; EA 3878 GETBO IFR 148, Brest, France; Université de Bretagne Occidentale, Brest, France., Ben Salem D; Radiology Department, University Hospital, Brest, France; Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM 1101, Brest, France., Querellou S; Nuclear Medicine Department, University Hospital, Brest, France; EA 3878 GETBO IFR 148, Brest, France; Université de Bretagne Occidentale, Brest, France., Schick U; Radiation Oncology Department, University Hospital, Brest, France; Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM 1101, Brest, France.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2020 Sep; Vol. 150, pp. 164-171. Date of Electronic Publication: 2020 Jun 21.

Zobrazit plný text záznamu

Akademický článek

Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.

Autor: Kebir S; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany. Electronic address: sied.kebir@uk-essen.de., Rauschenbach L; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany; Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: laurel.rauschenbach@uk-essen.de., Gielen GH; Institute of Neuropathology, University Hospital Bonn, University of Bonn, Bonn, Germany. Electronic address: gerrit.gielen@ukb.uni-bonn.de., Schäfer N; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany. Electronic address: niklas.schaefer@ukbonn.de., Tzaridis T; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany. Electronic address: theophilos.tzaridis@ukbonn.de., Scheffler B; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany. Electronic address: b.scheffler@dkfz-heidelberg.de., Giordano FA; Department of Radiation Oncology, University Hospital Mannheim, University of Mannheim, Germany. Electronic address: frank.giordano@umm.de., Lazaridis L; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany. Electronic address: lazaros.lazaridis@uk-essen.de., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany. Electronic address: ulrich.herrlinger@ukb.uni-bonn.de., Glas M; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany; West German Cancer Center (WTZ) & German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, University Duisburg-Essen, Essen, Germany; Division of Translational Oncology/Neurooncology, German Cancer Consortium (DKTK) Partner Site, University Hospital Essen, Essen, Germany. Electronic address: martin.glas@uk-essen.de.

Publikováno v: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2018 Jul; Vol. 53, pp. 255-258. Date of Electronic Publication: 2018 May 10.

Zobrazit plný text záznamu

Akademický článek

Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.

Autor: Bette S; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Gempt J; Department of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Delbridge C; Department of Neuropathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Kirschke JS; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Schlegel J; Department of Neuropathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Foerster S; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Huber T; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Pyka T; Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Zimmer C; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Ringel F; Department of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address: florian.ringel@tum.de.

Publikováno v: World neurosurgery [World Neurosurg] 2016 May; Vol. 89, pp. 230-9. Date of Electronic Publication: 2016 Mar 09.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání